Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway | |
Jianling Yang; Yuan Liao; Liping Sun; Riyue Feng; Ke Chen; Ji-Long Chen; Guijie Guo; Shile Huang; Xuefei Wang; Lianfeng Zhang | |
刊名 | Molecular Cancer |
2019 | |
卷号 | Vol.18 No.1 |
关键词 | LncRNA Imatinib Bcr-Abl Cellular transformation Leukemia |
ISSN号 | 1476-4598 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2205965 |
专题 | 安徽大学 |
作者单位 | 1.University of Chinese Academy of Sciences,Beijing,China 2.Department of Blood Transfusion,Chinese PLA General Hospital,Beijing,China 3.Key Laboratory of Fujian-Taiwan Animal Pathogen Biology,College of Animal Sciences, Fujian Agriculture and Forestry University,Fuzhou,China 4.Department of Immunology, Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province,Hebei Medical University,Shijiazhuang,China 5.Institute of Physical Science and Information Technology,Anhui University,Hefei,China 6.Department of Biochemistry and Molecular Biology,Louisiana State University Health Sciences Center,Shreveport,USA 7.CAS Key Laboratory of Pathogenic Microbiology and Immunology,Institute of Microbiology, Chinese Academy of Sciences ,Beijing,China 8.Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences & Comparative Medical Center,Peking Union Medical College,Beijing,China |
推荐引用方式 GB/T 7714 | Jianling Yang,Yuan Liao,Liping Sun,et al. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway[J]. Molecular Cancer,2019,Vol.18 No.1. |
APA | Jianling Yang.,Yuan Liao.,Liping Sun.,Riyue Feng.,Ke Chen.,...&Lianfeng Zhang.(2019).Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway.Molecular Cancer,Vol.18 No.1. |
MLA | Jianling Yang,et al."Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway".Molecular Cancer Vol.18 No.1(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论